Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma

Clinical trial NCT00729053 · COMPLETED

Trial details

NCT number: NCT00729053
Sponsor: Idera Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2004-06-01
Primary completion: 2008-04-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.